Chlamydia/Neisseria/Trichomonas – genetic testing

• The test should not be performed:
  – during menstruation,
  – during antibiotic treatment,
  – during treatment with vaginal preparations (pessories, creams),
  – when using douches,
  – within 48 hours of the last sexual intercourse.
  On the day of the test, wash the external genital area with a mild intimate hygiene gel; do not use soap.
  If treatment was used, a 3-5-day break is recommended between the end of treatment
  and the test.
• The test material may be a swab from the cervix, vagina, or urethral meatus, depending on clinical indications or the referring physician's recommendations. A swab is collected from one of these areas.

• The material for testing may be a swab from the urethral meatus or the sulcus retroglandularis, depending on clinical indications or the referring physician's recommendations. A swab is collected from one of these areas.
• Preparation for the examination:
  – refrain from sexual intercourse 48 hours before the examination
  – do not use antibiotics or medicated creams 48 hours before the examination
  – refrain from performing genital hygiene procedures 48 hours before the examination

Samples brought from outside the clinic are not accepted for testing.
A document must be attached: "Referral and consent for genetic testing (HPV, Chlamydia trachomatis) LUXMED." Available in the Patient Essentials - Downloadable Forms

Genetic testing for sexually transmitted infections (STIs).
STIs are often confused with each other due to their mode of transmission, risk factors, and symptoms. Treatment varies for some of them, so identifying the infectious agent is crucial.
The test uses a PCR test that detects the presence of three pathogens causing STIs in a single test: Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.
The most important risk factors for urogenital infections include:
• a large number and/or frequent changes of sexual partners
• use of oral contraceptives
• antibiotic therapy
• immunocompromised states
• certain diseases, e.g. diabetes, cancer
• pregnancy (increased susceptibility)
Untreated infections lead to serious complications such as pelvic inflammatory disease, urethritis, premature birth, developmental defects in the unborn child (low birth weight, neurological disorders, blindness), and infertility.
Some infections may be asymptomatic and lead to infection of the sexual partner. The test is also used after previous treatment to confirm its effectiveness.
NOTE:
Pursuant to the Regulation of the Minister of Health of June 26, 2020 (Journal of Laws of 2020, item 1118), a positive test result is subject to mandatory reporting by the laboratory performing the test to the District Sanitary and Epidemiological Station.

Enter one-time code: Show
Invalid code entered. Please try again.